Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review.

@article{Kim2013AllergenspecificIF,
  title={Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review.},
  author={Julia M. Kim and Sandra Y. Lin and Catalina Suarez-Cuervo and Yohalakshmi Chelladurai and Murugappan Ramanathan and J Bradley Segal and Nkiruka Erekosima},
  journal={Pediatrics},
  year={2013},
  volume={131 6},
  pages={1155-67}
}
BACKGROUND AND OBJECTIVE Subcutaneous immunotherapy (SCIT) is approved in the United States for the treatment of pediatric asthma and rhinitis; sublingual immunotherapy (SLIT) does not have regulatory approval but is used in clinical practice. The objective of this study was to systematically review the evidence regarding the efficacy and safety of SCIT and… CONTINUE READING

1 Figure or Table